ArticleEuropean journal of pediatrics2014

The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.

Nobuyuki Yamamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.